Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive PropertiesChristian P. Larsen, Robert Peach, Nozomu Shirasugi et al.|American Journal of Transplantation|2005Cited by 708
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.Robert Peach, Peter S. Linsley, JoAnne L. Greene et al.|The Journal of Experimental Medicine|1994Cited by 246